<- Go home

Added to YB: 2024-07-25

Pitch date: 2024-07-24

A [bullish]

Agilent Technologies, Inc.

+5.29%

current return

Author Info

Company Info

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Market Cap

$29.4B

Pitch Price

$132.66

Price Target

168.00 (+20%)

Dividend

0.96%

EV/EBITDA

16.95

P/E

23.63

EV/Sales

4.81

Sector

Life Sciences Tools and Services

Category

growth

Show full summary:
Agilent Technologies, Inc. - $A

A: #1-2 in lab instruments/services. Strong margins, FCF. 56% recurring rev. 6-8% market growth. New CEO risk. Fair value at 31x PE. Doubled API capacity for oligonucleotides. $3.3B market opportunity. Recent BIOVECTRA acquisition adds biologics, GLP-1 capabilities. Diversified across markets/geographies. $168 PT.

Read full article (8 min)